Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Looks At Speeding Up TCM Standardization

This article was originally published in PharmAsia News

Executive Summary

According to China's Chamber of Commerce of Medicines & Health Products Importers & Exporters, Korea will raise the standard on Chinese medicinal materials beginning April 7. The move will negatively impact China's export of traditional medicinal materials, which face quality issues. A local expert expresses concern about the possible influx of foreign higher-standard TCM preparations into the domestic market, especially from Japanese pharmaceutical companies, which are exploring their expansion into China. The government is taking initial measures to raise the quality of domestic Chinese medicinal materials and collaborate with overseas partners to establish international standards. (Click here for more - Chinese Language)

You may also be interested in...



US Probiotics Market Stirs With Chobani Beverages, Danone, Sofar And Plexus Blends For Kids

Chobani introduces Chobani Probiotic, its first functional probiotics beverage to support digestive and immune health; Danone North America extends its Danimals children’s yogurt line with products to support immune system; and Plexus Worldwide and Sofar Americas roll out children’s probiotics.

Social Media Posts Showed Almost 1,500 Adverse Events, 53 Deaths Linked To Essure: FDA Report

Report quantifies social media posts describing adverse events involving the Essure contraceptive device, which was pulled from the market amid safety concerns.

Cellular Biomedicine To Go Private In Consortium Buyout

Deal Snapshot: The China/US CAR-T firm will be bought out by its management team and institutional investors in a deal structured as a merger into a new company.

UsernamePublicRestriction

Register

LL1129788

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel